Sun Pharmaceuticals Industries (BOM:524715) Short-Term Capital Lease Obligation : ₹1,368 Mil (As of Mar. 2025)

View and export this data going back to 1994. Start your Free Trial

What is Sun Pharmaceuticals Industries Short-Term Capital Lease Obligation?

Sun Pharmaceuticals Industries's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was ₹1,368 Mil.

Sun Pharmaceuticals Industries's quarterly Short-Term Capital Lease Obligation declined from Sep. 2024 (₹1,239 Mil) to Dec. 2024 (₹0 Mil) but then increased from Dec. 2024 (₹0 Mil) to Mar. 2025 (₹1,368 Mil).

Sun Pharmaceuticals Industries's annual Short-Term Capital Lease Obligation declined from Mar. 2023 (₹1,281 Mil) to Mar. 2024 (₹1,257 Mil) but then increased from Mar. 2024 (₹1,257 Mil) to Mar. 2025 (₹1,368 Mil).

Sun Pharmaceuticals Industries Short-Term Capital Lease Obligation Historical Data

The historical data trend for Sun Pharmaceuticals Industries's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharmaceuticals Industries Short-Term Capital Lease Obligation Chart

Sun Pharmaceuticals Industries Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

1,016.70

1,078.20

1,280.80

1,256.90

1,368.20

Sun Pharmaceuticals Industries Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															1,256.90	-	1,239.40	-	1,368.20

Sun Pharmaceuticals Industries Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Sun Pharmaceuticals Industries Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Sun Pharmaceuticals Industries's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Sun Pharmaceuticals Industries Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharmaceuticals Industries Ltd (BOM:524715) » Definitions » Short-Term Capital Lease Obligation

Traded in Other Exchanges

SUNPHARMA:India

Address

Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063

Website

https://www.sunpharma.com

Sun Pharmaceuticals Industries Ltd is India's generic pharmaceutical manufacturing company. The company's substantial markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is majorly based in India.

Sun Pharmaceuticals Industries Headlines

No Headlines